Sa-Ford

Executive Summary

Sa-Ford is an Indian contract research organization (CRO) providing non-clinical chemistry, mutagenicity, and toxicology services to pharmaceutical and biotech sponsors. Founded in 2020 and headquartered in Mumbai, the company offers in-vivo and in-vitro studies compliant with OECD, ICHA, ICH, and CIPAC guidelines, covering analytical chemistry, physico-chemical characterization, impurity profiling, and reproductive toxicity testing. Leveraging controlled animal facilities and advanced analytical platforms, Sa-Ford supports drug development programs across therapeutic areas. As a well-positioned CRO in India's cost-effective research ecosystem, the company benefits from growing global demand for outsourced preclinical services, though its private status and lack of disclosed funding limit visibility into its growth trajectory.

Upcoming Catalysts (preview)

• H2 2026Securing new multi-client contracts with global pharma companies50% success
• Q1 2027Expansion of service offerings into new regulatory toxicology areas40% success
• Q4 2026Accreditation or certification from international regulatory bodies45% success